| 2024-06-11 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 2,380 0.0033% | $22.64 | $53,886 | +0.3% | |
| 2024-03-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 619 0.0009% | $28.33 | $17,536 | -22.13% | |
| 2023-12-14 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 514 0.0009% | $20.76 | $10,671 | -1.45% | |
| 2023-09-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 531 0.001% | $50.34 | $26,731 | -56.72% | |
| 2023-06-16 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 78,200 0.1671% | $54.78 | $4.28M | -57.62% | |
| 2023-06-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 509 0.0011% | $55.16 | $28,076 | -59.3% | |
| 2022-12-29 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 20,316 0.0412% | $51.05 | $1.04M | -16.92% | |
| 2022-12-28 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 1,700 0.0037% | $50.00 | $85,006 | -9.81% | |
| 2022-11-16 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 3,947 0.0084% | $45.47 | $179,464 | -1.64% | |
| 2022-11-15 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 3,138 0.0068% | $45.04 | $141,343 | +0.48% | |
| 2022-10-26 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 4,762 0.0107% | $45.03 | $214,433 | +5.33% | |
| 2022-10-25 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 10,653 0.0234% | $45.09 | $480,349 | +2.42% | |
| 2022-10-06 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 22,500 0.0482% | $39.29 | $884,025 | +14.6% | |
| 2022-09-30 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 45,000 0.0925% | $32.72 | $1.47M | +31.84% | |
| 2022-09-13 | Sale | Akero Therapeutics, Inc. AKRO | Chief Scientific Officer | 22,500 0.0585% | $29.18 | $656,550 | +53.99% |